Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)
Joerger, M, Baty, F, Früh, M, Droege, C, Stahel, R.A, Betticher, D.C, von Moos, R, Ochsenbein, A, Pless, M, Gautschi, O, Rothschild, S, Brauchli, P, Klingbiel, D, Zappa, F, Brutsche, M
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2014)
Get full text
Journal Article
341 EXPRESSION OF DIFFERENT ISOFORMS OF MDR3 FROM HUMAN LIVER
Cajani, S, Droege, C, Stindt, J, Stross, C, Häussinger, D, Kubitz, R
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
Orlistat‐induced fulminant hepatic failure
Sall, D., Wang, J., Rashkin, M., Welch, M., Droege, C., Schauer, D.
Published in Clinical obesity (01.12.2014)
Published in Clinical obesity (01.12.2014)
Get full text
Journal Article
9147 Bevacizumab and erlotinib as first-line therapy in advanced (stage IIIB/IV) non-squamous non-small-cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression – a multicenter phase II trial of SAKK
Zappa, F, Droege, C, Betticher, D, von Moos, R, Ochsenbein, A, Stahel, R, Rauch, D, Schmid, P, Mayer, M, Pless, M
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Intrahepatic cholestasis of pregnancy (ICP): case report and review of the literature
Keitel, V, Dröge, C, Stepanow, S, Fehm, T, Mayatepek, E, Köhrer, K, Häussinger, D
Published in Zeitschrift fur Gastroenterologie (01.12.2016)
Published in Zeitschrift fur Gastroenterologie (01.12.2016)
Get more information
Journal Article
A phase II study of tumor-treating fields (TTF) in combination with pemetrexed for advanced non-small cell lung cancer (NSCLC: Updated survival results
Pless, M., Betticher, D. C., Droege, C., Cathomas, R., Weinberg, U.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Whole blood transcriptomics analysis of 24h responses to bevacizumab/erlotinib in nonsquamous non-small cell lung cancer: A multicenter phase II trial SAKK19/05
Baty, F., Frueh, M., Crowe, S., Droege, C., Betticher, D. C., Cathomas, R., Zappa, F., Pless, M., Brutsche, M. H.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Exonic expression variations of EGFR and KRAS in small bronchoscopic biopsies from patients with advanced non-small cell lung cancer treated by combined bevacizumab/erlotinib therapy followed by platinum-based chemotherapy at disease progression: A multicenter phase II trial SAKK19/05
Brutsche, M. H., Frueh, M., Crowe, S., Droege, C., Betticher, D. C., von Moos, R., Zappa, F., Pless, M., Bubendorf, L., Baty, F.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Everolimus as first-line therapy in nonrapidly progressive metastatic castration-resistant prostate cancer (mCRPC): A multicenter phase II trial (SAKK 08/08)
Templeton, A., Rothermundt, C., Cathomas, R., Baertschi, D., Droege, C., Gautschi, O., Borner, M. M., Fechter, E., Stenner, F., Winterhalder, R. C., Mueller, B., Dutoit, V., Dietrich, P., Schiess, R., Wild, P., Thalmann, G. N., Klingbiel, D., Gillessen, S.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Cetuximab in combination with docetaxel in patients (pts) with metastatic castration resistant (mCRPC) and docetaxel-refractory prostate cancer: A multicenter phase II trial (SAKK 08/07)
Cathomas, R., Rothermundt, C., von Moos, R., Betticher, D. C., Winterhalder, R. C., Droege, C., Siciliano, D., Berthold, D. R., Pless, M., Gillessen, S.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Bevacizumab (B) and erlotinib (E) as first-line therapy in metastatic nonsquamous non-small cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression (PD): A multicenter phase II trial, SAKK 19/05
Zappa, F., Droege, C., Betticher, D. C., von Moos, R., Brutsche, M. H., Baty, F., Bubendorf, L., Ochsenbein, A., Oppliger Leibundgut, E., Gautschi, O., Froesch, P., Stahel, R. A., Rauch, D., Schmid, P., Mayer, M., Crowe, S., Brauchli, P., Ribi, K., Pless, M.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase I study of the oral platinum agent satraplatin (S) in sequential combination with capecitabine (C) in patients with advanced solid tumours
Sessa, C., Hess, D., Bauer, J., Droege, C., Gallerani, E., Miani, M., Tinazzi, A., Krieter, O., Angst, R., Nay, C.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article